Mediplantex National Pharmaceutical JSC (HNX:MED)
Vietnam · Delayed Price · Currency is VND 20,400
0.00 (0.00%)
At close: Mar 31, 2026
HNX:MED Revenue
In the year 2025, Mediplantex National Pharmaceutical JSC had annual revenue of 366.83B VND, down -17.22%. Mediplantex National Pharmaceutical JSC had revenue of 117.36B in the quarter ending December 31, 2025, with 10.80% growth.
Revenue
366.83B
Revenue Growth
-17.22%
P/S Ratio
0.69
Revenue / Employee
1.18B
Employees
310
Market Cap
253.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 366.83B | -76.31B | -17.22% |
| Jan 1, 2025 | 443.14B | 40.39B | 10.03% |
| Jan 1, 2024 | 402.74B | 1.69B | 0.42% |
| Dec 31, 2022 | 401.05B | 57.10B | 16.60% |
| Dec 31, 2021 | 343.95B | -177.44B | -34.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vimedimex Medi-Pharma JSC | 1.17T |
| OPC Pharmaceutical JSC | 1.12T |
| Vidipha Central Pharmaceutical JSC | 950.89B |
| Ben Tre Pharmaceutical JSC | 860.40B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Central Pharmaceutical Joint Stock Company No3 | 438.01B |
| SPM Corporation | 253.96B |
| Lamdong Pharmaceutical JSC | 243.91B |